Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

AIFF

Firefly Neuroscience (AIFF)

Firefly Neuroscience Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AIFF
DataHoraFonteTítuloCódigoCompanhia
14/02/202518:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AIFFFirefly Neuroscience Inc
14/02/202502:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AIFFFirefly Neuroscience Inc
11/02/202509:45GlobeNewswire Inc.Firefly Neuroscience Accepted into NVIDIA Connect ProgramNASDAQ:AIFFFirefly Neuroscience Inc
07/02/202509:30GlobeNewswire Inc.Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum ElectronicsNASDAQ:AIFFFirefly Neuroscience Inc
24/01/202511:00GlobeNewswire Inc.Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric CareNASDAQ:AIFFFirefly Neuroscience Inc
21/01/202511:10Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AIFFFirefly Neuroscience Inc
14/01/202517:50AllPennyStocks.comThis Micro Cap Soared On Key AnnouncementNASDAQ:AIFFFirefly Neuroscience Inc
14/01/202509:45GlobeNewswire Inc.Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ PlatformNASDAQ:AIFFFirefly Neuroscience Inc
08/01/202518:45Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AIFFFirefly Neuroscience Inc
08/01/202518:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AIFFFirefly Neuroscience Inc
31/12/202411:00GlobeNewswire Inc.Firefly Neuroscience Closes on Financing of up to $12.4 MillionNASDAQ:AIFFFirefly Neuroscience Inc
06/12/202419:16Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AIFFFirefly Neuroscience Inc
04/12/202411:00GlobeNewswire Inc.Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive ChairmanNASDAQ:AIFFFirefly Neuroscience Inc
04/12/202408:16Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AIFFFirefly Neuroscience Inc
14/11/202419:30GlobeNewswire Inc.Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder UpdateNASDAQ:AIFFFirefly Neuroscience Inc
14/11/202419:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AIFFFirefly Neuroscience Inc
06/11/202411:00GlobeNewswire Inc.Firefly Neuroscience to Participate in the 8th Annual Florida Capital EventNASDAQ:AIFFFirefly Neuroscience Inc
25/10/202417:10GlobeNewswire Inc.Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AIFFFirefly Neuroscience Inc
24/10/202417:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AIFFFirefly Neuroscience Inc
21/10/202409:30GlobeNewswire Inc.Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG DataNASDAQ:AIFFFirefly Neuroscience Inc
16/10/202410:20GlobeNewswire Inc.Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ TechnologyNASDAQ:AIFFFirefly Neuroscience Inc
15/10/202410:00GlobeNewswire Inc.Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive DisorderNASDAQ:AIFFFirefly Neuroscience Inc
11/10/202410:00GlobeNewswire Inc.Firefly Neuroscience to Participate in Upcoming October Investor ConferencesNASDAQ:AIFFFirefly Neuroscience Inc
27/09/202407:22Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AIFFFirefly Neuroscience Inc
20/09/202410:00GlobeNewswire Inc.Firefly Neuroscience Advances AI-Driven BNA™ Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and NovartisNASDAQ:AIFFFirefly Neuroscience Inc
10/09/202410:00GlobeNewswire Inc.Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device PlatformNASDAQ:AIFFFirefly Neuroscience Inc
05/09/202410:00GlobeNewswire Inc.Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of DirectorsNASDAQ:AIFFFirefly Neuroscience Inc
26/08/202410:00GlobeNewswire Inc.Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11NASDAQ:AIFFFirefly Neuroscience Inc
22/08/202410:00GlobeNewswire Inc.Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4thNASDAQ:AIFFFirefly Neuroscience Inc
21/08/202410:00GlobeNewswire Inc.Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive DisordersNASDAQ:AIFFFirefly Neuroscience Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AIFF